Single Dose Radiotherapy Services Market Report 2026

The single dose radiotherapy services market size has grown strongly in recent years. It will grow from $1.6 billion in 2025 to $1.73 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to limited access to conventional radiotherapy, rising cancer incidence, high patient preference for outpatient care, growth in radiotherapy equipment availability, early adoption of single dose protocols.

The single dose radiotherapy services market size is expected to see strong growth in the next few years. It will grow to $2.27 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to advancements in precision radiotherapy technology, integration of AI and robotics, increasing reimbursement coverage, growth in oncology-focused healthcare centers, rising adoption in emerging economies. Major trends in the forecast period include increasing use of hypofractionated radiotherapy, adoption of image-guided radiotherapy, growth in mobile and remote radiotherapy units, integration of AI in treatment planning, expansion of patient-centric oncology care.

The rising prevalence of cancer is expected to drive the growth of the single-dose radiotherapy services market in the coming years. Cancer encompasses a group of diseases marked by uncontrolled cell proliferation, often resulting in tumors that can invade surrounding tissues and spread to other parts of the body, disrupting normal physiological functions. The growing burden of cancer is attributed to factors such as aging populations, lifestyle changes, environmental exposures, and improvements in detection and diagnostic technologies. Single-dose radiotherapy services help address the increasing incidence of cancer by providing rapid and effective treatment that precisely targets and destroys cancer cells, potentially improving patient outcomes and reducing the overall disease burden. For example, in July 2024, the Australian Institute of Health and Welfare, an Australia-based government agency, reported that in 2023, approximately 165,000 Australians were newly diagnosed with cancer, equivalent to more than 450 new cases per day, with males accounting for around 55% of diagnoses. Therefore, the growing prevalence of cancer is fueling the expansion of the single-dose radiotherapy services market.

Key players in the single-dose radiotherapy services market are increasingly emphasizing the development of innovative solutions, such as advanced radiation therapy computed tomography (CT) systems, to improve imaging accuracy and streamline simulation workflows in oncology care. Advanced radiation therapy CT solutions are designed to enhance treatment precision, while AI-enabled intelligent radiation therapy (iRT) platforms leverage artificial intelligence to optimize and personalize radiation therapy planning. For instance, in May 2024, GE HealthCare, a US-based medical technology company, introduced Revolution RT along with an updated Intelligent Radiation Therapy (IRT) platform. These offerings deliver improved imaging accuracy, greater workflow efficiency, and AI-driven personalization, with Revolution RT enabling precise radiotherapy simulation and the enhanced IRT platform simplifying workflows and improving treatment accuracy. Such technological advancements significantly enhance imaging precision, workflow efficiency, and personalization, thereby improving the effectiveness, accessibility, and efficiency of single-dose radiotherapy services.

In May 2024, Novartis AG, a US-based healthcare company specializing in pharmaceuticals and biotechnology, acquired Mariana Oncology, Inc. for an undisclosed amount. Through this acquisition, Novartis aims to strengthen its precision oncology portfolio by incorporating Mariana Oncology’s innovative radioligand therapies, which are designed to more accurately target and treat cancer. This move enhances Novartis’s position in the oncology market and supports its strategy of delivering transformative cancer treatments. Mariana Oncology, Inc. is a US-based company focused on developing radioligand therapies for cancer treatment.

Major companies operating in the single dose radiotherapy services market are Hitachi Ltd, Varian Medical Systems Inc, Boston Scientific Corporation, Elekta AB, GenesisCare, Accuray Incorporated, IBA Dosimetry GmbH, ViewRay Inc, RaySearch Laboratories AB, RefleXion Medical Inc, Sensus Healthcare Inc, C-RAD AB, Panacea Medical Technologies Pvt Ltd, Advanced Oncotherapy Plc, ProTom International Inc, Isoray Inc, IntraOp Medical Corporation, Alliance Oncology, Nanobiotix, Xcision Medical Systems LLC, Oraya Therapeutics Inc, Mevion Medical Systems, Theragenics Corporation, Oncology Imaging Systems.

North America was the largest region in the single dose radiotherapy services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single dose radiotherapy services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the single dose radiotherapy services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the single dose radiotherapy services market by increasing the cost of imported radiation equipment, imaging systems, software, and precision components used in high-dose radiotherapy delivery. Specialized cancer institutes and radiotherapy centers in Asia-Pacific and Latin America face higher installation and maintenance expenses. These cost pressures can slow the expansion of stereotactic and brachytherapy services. However, tariffs are encouraging local equipment servicing and technology partnerships, strengthening operational sustainability in the single dose radiotherapy services market.

The single dose radiotherapy services market research report is one of a series of new reports that provides single dose radiotherapy services market statistics, including single dose radiotherapy services industry global market size, regional shares, competitors with a single dose radiotherapy services market share, detailed single dose radiotherapy services market segments, market trends and opportunities, and any further data you may need to thrive in the single dose radiotherapy services industry. This single dose radiotherapy services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Single-dose radiotherapy services involve a cancer treatment method in which a single, high dose of radiation is delivered to a tumor during one session. These services provide convenience by minimizing hospital visits, offering rapid symptom relief, and are commonly used in palliative care to enhance patients’ quality of life.

The main types of single-dose radiotherapy services include internal beam radiotherapy and external beam radiotherapy. Internal beam radiotherapy, also known as brachytherapy, is a treatment approach that places a radioactive source directly within or close to the tumor. This technique delivers high radiation doses to the cancerous tissue while limiting exposure to surrounding healthy tissues. The key applications include prostate cancer and breast cancer, and the services are provided by specialized cancer institutes and radiotherapy centers.

The single-dose radiotherapy services market includes revenues earned by entities by providing services such as palliative care services, radiation delivery, radiotherapy treatment planning, regular monitoring, and patient consultation and related linear accelerators, imaging systems, immobilization devices, beam shaping devices, and radiation safety equipment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.